Patents by Inventor Claude James

Claude James has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7511219
    Abstract: An expandable while-in-use cover includes: a cap having a pair of cap side walls, a first cap end wall, a second cap end wall and a top wall, which define a cap opening and a cap interior; a base having a pair of base side walls, a first base end wall, a second base end wall and a back wall, which define a base opening and a base exterior, wherein the base side walls and base end walls correspond to the cap side walls and cap end walls and wherein the cover is adapted to slidably and/or telescopically receive the base; a first and second prong on the interior of each of the cap side walls near the first and second cap end walls; a first and second slotted track on the exterior of each of the base side walls near the base end walls, wherein the first slotted track of each base side wall is adapted to receive the first prong of each cap side wall and the second slotted track of each base side wall is adapted to receive the second prong of each cap side wall; and an aperture in the back wall for accessing an ele
    Type: Grant
    Filed: March 4, 2008
    Date of Patent: March 31, 2009
    Assignee: Thomas & Betts International, Inc.
    Inventors: Cong Thanh Dinh, Claude James Bauer
  • Publication number: 20080210452
    Abstract: An expandable while-in-use cover includes: a cap having a pair of cap side walls, a first cap end wall, a second cap end wall and a top wall, which define a cap opening and a cap interior; a base having a pair of base side walls, a first base end wall, a second base end wall and a back wall, which define a base opening and a base exterior, wherein the base side walls and base end walls correspond to the cap side walls and cap end walls and wherein the cover is adapted to slidably and/or telescopically receive the base; a first and second prong on the interior of each of the cap side walls near the first and second cap end walls; a first and second slotted track on the exterior of each of the base side walls near the base end walls, wherein the first slotted track of each base side wall is adapted to receive the first prong of each cap side wall and the second slotted track of each base side wall is adapted to receive the second prong of each cap side wall; and an aperture in the back wall for accessing an ele
    Type: Application
    Filed: March 4, 2008
    Publication date: September 4, 2008
    Inventors: Cong Thanh Dinh, Claude James Bauer
  • Patent number: 7374058
    Abstract: An expandable while-in-use cover includes: a cap having a pair of cap side walls, a first cap end wall, a second cap end wall and a top wall, which define a cap opening and a cap interior; a base having a pair of base side walls, a first base end wall, a second base end wall and a back wall, which define a base opening and a base exterior, wherein the base side walls and base end walls correspond to the cap side walls and cap end walls and wherein the cover is adapted to slidably and/or telescopically receive the base; a first and second prong on the interior of each of the cap side walls near the first and second cap end walls; a first and second slotted track on the exterior of each of the base side walls near the base end walls, wherein the first slotted track of each base side wall is adapted to receive the first prong of each cap side wall and the second slotted track of each base side wall is adapted to receive the second prong of each cap side wall; and an aperture in the back wall for accessing an ele
    Type: Grant
    Filed: July 14, 2005
    Date of Patent: May 20, 2008
    Assignee: Thomas & Betts International, Inc.
    Inventors: Cong Thanh Dinh, Claude James Bauer
  • Patent number: 5468888
    Abstract: The present invention relates to new lupane dervivatives of the general formula: ##STR1## to their salts, to their preparation and to the pharmaceutical compositions which contain them.
    Type: Grant
    Filed: May 12, 1994
    Date of Patent: November 21, 1995
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Romaine Bouboutou, Norbert Dereu, Michel Evers, Jean-Christophe Gueguen, Claude James, Christele Poujade, Daniel Reisdorf, Yves Ribeill, Francoise Soler
  • Patent number: 5236940
    Abstract: Pharmaceutical compositions are disclosed. They are useful for the treatment of medical conditions associated with the effects of glutamate, comprise as active principle, at least one compound of formula: ##STR1## or a salt thereof, in which either R.sub.1 represents polyfluoroalkoxy, 2,2,2-trifluoroethyl, pentafluoroethyl, tert-butyl, trimethylsilyl or trifluoromethylthio and R.sub.2 and R.sub.3 represent hydrogen,or R.sub.1 represents polyfluoroalkoxy, R.sub.2 represents hydrogen and R.sub.3 represents alkyl, amino, alkoxy, phenyl, phenylalkyl, dimethylamino or dialkylaminoakylthio,or R.sub.1 represents polyfluoroalkoxy, R.sub.2 represents amino and R.sub.3 represents hydrogen, with the exception of 6-trifluoromethoxy-2-benzothiazolamine.
    Type: Grant
    Filed: September 3, 1991
    Date of Patent: August 17, 1993
    Assignee: Rhone-Poulenc Sante
    Inventors: Francois Audiau, Claude James
  • Patent number: 5120852
    Abstract: Process for preparing (1R,2R)-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxides of general formula: ##STR1## (R.sub.1 =alkyl containing 1 to 4 carbon atoms), by the action of an alkyl isothiocyanate on the 1R,2R and 1R,2S sulphoxides of formulae: ##STR2## employed alone or mixed, the (1R,2R)-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxides thereby obtained and pharmaceutical compositions containing them.(1R,2R)-2-(3-Pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxides are especially useful as antihypertensives.
    Type: Grant
    Filed: October 31, 1990
    Date of Patent: June 9, 1992
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Claude Aloup, Claude James, Rodolphe Margraff
  • Patent number: 5086051
    Abstract: New derivatives of formula (I) in which R.sub.1 =H, halogen, alkyl, alkyloxy, CF.sub.3, NH.sub.2, alkylamino, dialkylamino, OH, CH, phenyl or phenoxy, Ar=phenyl, naphthyl, pyridyl, quinolyl, isoquinolyl, thienyl, thieno[2,3-b]thienyl or thieno[3,2-b]thienyl (these groups optionally substituted with halogen, alkyl, alkyloxy, CF.sub.3, NH.sub.2, alkylamino, dialkylamino, OH or CN), p=0, 1 or 2, andA--either Z=valency bond and R.sub.2 =HB--or Z=valency bond and R.sub.2 =pyridyl, quinuclidinyl, 3-pyrrolidinyl, 3- or 4-piperidyl (these groups optionally being substituted with alkyl, hydroxyalkyl, phenyl or phenylalkyl)C--or Z=alkylene radical (1 to 4C) and R.sub.2 =2-, 3- or 4-pyridyl, 3-quinuclidinyl, 2- or 3-pyrrolidinyl, 2-, 3- or 4-piperidyl (optionally substituted with alkyl, hydroxyalkyl, phenyl or phenylalkyl) or R.sub.2 =CON(R.sub.3)(R.sub.4) wherea) either R.sub.3 and R.sub.4 form a piperazine optionally substituted with alkyl, hydroxyalkyl, pyridyl, phenyl or phenylalkyl,b) or R.sub.
    Type: Grant
    Filed: March 14, 1990
    Date of Patent: February 4, 1992
    Assignee: Rhone-Poulenc Sante
    Inventors: Claude James, Daniel Lave, Francoise Soler
  • Patent number: 4916119
    Abstract: Tripeptides of the general formula: ##STR1## wherein the symbols R, which may be the same or different represent hydrogen or a fatty acid residue (at least one of them representing a fatty acid residue), R.sub.1 represents hydroxy, amino or alkoxy and R.sub.2 and R.sub.3, which may be the same or different, represent hydrogen, carboxy, carbamoyl or alkoxycarbonyl radical (with the proviso that R.sub.2 and R.sub.3 cannot simultaneously represent a hydrogen atom), the alanine moiety being in the L form, the glutamic acid moiety being in the D form, the lysine moiety (when R.sub.2 or R.sub.3 =a hydrogen atom) being in the L form and the 2,6-diaminopimelic acid moiety or its derivatives (when R.sub.2 and/or R.sub.3 =carboxy, carbamoyl or alkoxycarbonyl) being in the D,D, L,L, D,D/L,L (racemic) or D,L (meso) form, and salts thereof, possess immunological adjuvant and immunostimulant activity.
    Type: Grant
    Filed: June 27, 1980
    Date of Patent: April 10, 1990
    Assignee: Rhone-Poulenc Industries
    Inventors: Jean Bouchaudon, Daniel Farge, Claude James
  • Patent number: 4868326
    Abstract: N.sup.6 -Benzyloxycarbonyl-2,6-diaminopimelamic acid in L,L or D,D or racemic form is prepared by amidation of O.sup.1 -p-nitrobenzyl-N.sup.2 -benzyloxycarbonyl-2,6-diaminopimelic acid in L,L or D,D or racemic form.
    Type: Grant
    Filed: August 3, 1988
    Date of Patent: September 19, 1989
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean Bouchaudon, Daniel Farge, Claude James
  • Patent number: 4786645
    Abstract: A compound of the general formula I: ##STR1## in which Ar is a pyridyl, quinolinyl, isoquinolinyl, naphthyridinyl, pyrimidyl, quinazolinyl, thiazolyl, benzothiazolyl, imidazolyl, benzimidazolyl, oxazolyl, benzoxazolyl, thienyl, benzothienyl or naphthyl group; optionally substituted with one or more halogen or alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, alkylsulphinyl, alkylsulphonyl, sulphamido, alkylsulphamido, dialkylsulphamido, alkylcarbonyl, benzoyl, alkyloxycarbonyl, carboxy, phenoxycarbonyl, alkylcabonyloxy, benzoyloxy, alkylcarbonylamino, benzamido, phenyl, benzyl, phenoxy or phenylthio group, provided that (i) when Ar is a pyridyl group, the pyridyl group must be substituted, (ii) an alkyl moiety contains 1 to 4 straight- or branched chain carbon atoms; (iii) a phenyl moiety may be unsubstituted or substituted with one or more halogen or alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, phenyl or benzyl group
    Type: Grant
    Filed: July 2, 1987
    Date of Patent: November 22, 1988
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Louis Fabre, Claude James, Daniel Lave
  • Patent number: 4783472
    Abstract: A compound of the general formula I; ##STR1## in which R is hydrogen or a halogen or an alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, carboxy, alkylsulphinyl, alkylsulphonyl, sulphamido, alkylsulphamido, dialkylsulphamido, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, phenylcarbamoyl, diphenylcarbamoyl, pyridylcarbamoyl, dipyridylcarbamoyl, benzyl, alkylcarbonyl, benzoyl, alkyloxycarbonyl, phenoxycarbonyl, alkylcarbonyloxy, benzoyloxy, alkylcarbonylamino, benzamido, phenyl, phenoxy or phenylthio group, X is oxygen or sulphur or an imino, alkylimino, phenylimino, benzylimino, sulphinyl, sulphonyl, carbonyl, carbonylmethylene, methylenecarbonyl, carbonylvinylene or vinylenecarbonyl group, or X represents a valency bond or a straight-chain alkylene group containing 1 to 4 carbon atoms and Ar is a phenyl, naphthyl, pyridyl, quinolinyl, isoquinolinyl, thienyl, benzothienyl, thieno[3,2-b]thien-2-yl or thieno[2,3-b]thien-2-yl group, it being possible for the group Ar to
    Type: Grant
    Filed: July 2, 1987
    Date of Patent: November 8, 1988
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Louis Fabre, Claude James, Daniel Lave
  • Patent number: 4751234
    Abstract: Thioformamide derivatives of the formula: ##STR1## wherein R is hydrogen or alkyl (1 to 4 C), Het is pyridin-3-yl[optionally substituted by alkyl (1 to 4 C) or a halogen], quinolin-3-yl, pyridazin-4-yl, pyrimidin-5-yl, thiazol-5-yl, thieno[2,3-b]pyridin-5-yl or thieno[3,2-b]pyridin-6-yl, and Y is a valency bond or a methylene radical, are new compounds, which are particularly useful as antihypertensive agents.
    Type: Grant
    Filed: August 16, 1985
    Date of Patent: June 14, 1988
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Claude Aloup, Jean Bouchaudon, Daniel Farge, Claude James
  • Patent number: 4742048
    Abstract: Tetrapeptides and pentapeptides of the formula: ##STR1## wherein R represents hydrogen or a fatty acid residue, R.sub.1 represents hydroxy, amino, alkoxy of 1 to 4 carbon atoms, optionally substituted by phenyl or nitrophenyl, one of R.sub.2 and R.sub.4 represents hydrogen, carboxy, carbamoyl, alkoxycarbonyl of 2 to 5 carbon atoms, optionally substituted by phenyl or nitrophenyl, or a N-carbonylglycine or N-carbonyl-D-alanine radical optionally esterified by alkyl of 1 to 4 carbon atoms (which is optionally substituted by phenyl or nitrophenyl) and the other symbol represents hydrogen, carboxy, carbamoyl, or alkoxycarbonyl fof 2 to 5 carbon atoms, optionally substituted by phenyl or nitrophenyl, and R.sub.3 represents hydrogen, a fatty acid residue or a glycyl or D-alanyl moiety in which the amine group is optionally substituted by a fatty acid residue, it being understood that R.sub.2 and R.sub.4 cannot simutaneously represent hydrogen, that at least one of R.sub.2, R.sub.3 and R.sub.
    Type: Grant
    Filed: June 27, 1980
    Date of Patent: May 3, 1988
    Assignee: Rhone-Poulenc Industries
    Inventors: Jean Bouchaudon, Daniel Farge, Claude James
  • Patent number: 4684658
    Abstract: The invention provides novel pyrrole derivatives of formula: ##STR1## in which R'=H, alkyl or phenyl optionally substituted by halogen, alkyl, alkyloxy or alkylthio, Z=0 or S, p=0 or 1, andeither A is a heterocyclic ring such that it forms, with pyrrole, a 1H,3H-pyrrolo[1,2-c]thiazole, 2,3-dihydro-1H-pyrrolizine optionally substituted by OH, 5,6,7,8-tetrahydroindolizine, 1,2-dihydro-4H-pyrrolo[1,2-c]-1,3-thiazine, 2,3-dihydropyrrolo[2,1-b]thiazole, 1H,3H-pyrrolo[1,2-c]oxazole, 1,2-dihydro-4H-pyrrolo]1,2-c]-1,3-oxazine or 2,3-dihydropyrrolo[2,1-b]oxazole ring system, n=0 or 1, Het=3-pyridyl or 5-thiazolyl, and(1) either R=H, halogen, alkyl or phenyl optionally substituted by halogen, alkyloxy or alkylthio and Y=alkyl or phenyl optionally substituted by halogen, alkyl, alkyloxy or alkylthio, or Y=--NR.sub.1 R.sub.2 with:either R.sub.1 =H and R.sub.2 =unsubstituted alkyl, cycloalkyl (C.sub.3 -C.sub.6), alkenyl (C.sub.2 -C.sub.4), alkynyl (C.sub.3 -C.sub.
    Type: Grant
    Filed: December 20, 1984
    Date of Patent: August 4, 1987
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Louis Fabre, Daniel Farge, Claude James, Daniel Lave
  • Patent number: 4680303
    Abstract: Thioformamide derivatives of formula: ##STR1## in which R is hydrogen or alkyl (1 to 4 C), R.sub.1 is alkyl (1 to 4 C), and X denotes sulphur or oxygen and Y is sulphur, oxygen, methylene radical, or, when X is oxygen, a valency bond, are inhibitors of gastric secretion and therefore useful in the treatment of gastric ulcers. They may be made by reaction of an amine R--NH.sub.
    Type: Grant
    Filed: November 18, 1985
    Date of Patent: July 14, 1987
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean C. Aloup, Jean Bouchaudon, Daniel Farge, Claude James
  • Patent number: 4584297
    Abstract: Antithrombotics of the formula ##STR1## in which A=S, SO or SO.sub.2, R.sub.3 =H, alkyl or substituted or unsubstituted phenyl, X=O, S, NH or variously substituted nitrogen, p is 0 or 1 and y=H, NH.sub.2, or various substituted amines.
    Type: Grant
    Filed: April 10, 1985
    Date of Patent: April 22, 1986
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Louis Fabre, Daniel Farge, Claude James, Daniel Lave
  • Patent number: 4568682
    Abstract: Thioformamide derivatives of the formula: ##STR1## wherein R is hydrogen or alkyl (1 to 4 C), Het is pyridin-3-yl [optionally substituted by alkyl (1 to 4 C) or a halogen], quinolin-3-yl, pyridazin-4-yl, pyrimidin-5-yl, thiazol-5-yl, thieno[2,3-b]pyridin-5-yl or thieno[3,2-b]pyridin-6-yl, and Y is a valency bond or a methylene radical, are new compounds, which are particularly useful as antihypertensive agents.
    Type: Grant
    Filed: June 16, 1983
    Date of Patent: February 4, 1986
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Claude Aloup, Jean Bouchaudon, Daniel Farge, Claude James
  • Patent number: 4547504
    Abstract: Pyrrolidine derivatives of the formula: ##STR1## wherein X represents an oxygen or sulphur atom, R represents a hydrogen atom or an alkyl radical, R.sub.o represents a hydrogen atom, an alkyl radical or a phenyl radical optionally substituted by a halogen atom or by an alkyl, alkoxy, alkylthio or nitro radical, A represents a nitrogen atom or a radical .dbd.CH--, the symbol Y represents a hydrogen or halogen atom or an alkyl, alkoxy, alkylthio, alkylcarbonyl, nitro, amino, alkylcarbonylamino, alkylamino, dialkylamino, alkylsulphinyl, alkylsulphonyl, alkoxycarbonyl, cyano, trifluoromethyl, hydroxy, mercapto, alkylcarbonyloxy or alkylcarbonylthio radical, n represents zero or 1, and p represents 1, 2 or 3, it being understood that the alkyl and alkoxy radicals, and alkyl and alkoxy moieties of any of the aforementioned groups, contain from 1 to 4 carbon atoms are new therapeutically useful compounds, more particularly useful as antidepressants.
    Type: Grant
    Filed: December 6, 1983
    Date of Patent: October 15, 1985
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Louis Fabre, Daniel Farge, Claude James, Daniel Lave
  • Patent number: 4546100
    Abstract: Antithrombotics of the formula: ##STR1## wherein A is S, SO or SO.sub.2 ; R.sub.3 is H, alkyl or substituted or unsubstituted phenyl; p is zero or 1; X is O, S, N or variously substituted nitrogen; Y is H or various substituted amines.
    Type: Grant
    Filed: January 11, 1984
    Date of Patent: October 8, 1985
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Louis Fabre, Daniel Farge, Claude James, Daniel Lave
  • Patent number: 4539400
    Abstract: The invention provides new derivatives of the formula: ##STR1## in which either (a) Y=COOH or a radical of the formula (II), in which R.sub.2 =alkyl or benzyl, A=a sulphur atom, m=1, n=0, R=pyridin-3-yl and R.sub.1 =H, or (b) Y=CN, COOH or a radical of the formula ##STR2## defined as above, A=S, O or CH.sub.2, m=1 or 2 and n=0, 1 or 2, (m+n) being 1, 2 or 3, R=H, alkyl or phenyl (optionally substituted by halogen, alkyl, alkoxy or CF.sub.3) and R.sub.1 =a radical of the formula ##STR3## in which p=0 or 1, the alkyl radicals and alkyl portions being straight-chain or branched-chain and containing 1 to 4 carbon atoms each. Processes for the production of these compounds are described. They are useful as intermediates for the preparation of new medicaments.
    Type: Grant
    Filed: January 11, 1984
    Date of Patent: September 3, 1985
    Assignee: Rhone-Poulenc Sante
    Inventors: Jean-Louis Fabre, Daniel Farge, Claude James, Daniel Lave